Biotech startup Tenex Health Inc. has received commitments for $1.675 million in equity of an anticipated $2 million fundraise, according to a regulatory filing with the Securities and Exchange Commission.
The funding, with a minimum of $25,000 per investor, comes from 26 investors, according to the document.
The company in March reported that it raised $1.275 million of the $2 million goal.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Because Tenex doesn’t have a Web site and was founded last year, details on the company are scarce. The company is apparently developing treatments for sports-related injuries like tendinitis.
CEO Jagi Gill didn’t return a call.
Gill is a long-time medical device executive in Minnesota. He formerly worked at Mayo Clinic’s department of neurology and Boston Scientific Corp. where he was a top marketing and business development executive at its cardiovascular and neuromodulation units.
Photo from flicker user Foxtongue
